DAPT for secondary prevention in patients with ACS

Consensus Document

Jun 22
DAPT for secondary prevention in patients with ACS
Diana A. Gorog, Jose Luis Ferreiro, et al.
This consensus document provides practical advice on personalizing dual antiplatelet therapy duration and intensity in patients with acute coronary syndrome undergoing percutaneous coronary intervention, to optimize clinical outcomes.
open access

Flashlight

Jun 19
Transcatheter papillary muscle banding
Lukasz Tekieli, Piotr Musiałek, et al.
This study evaluates the use of transcatheter banding of papillary muscles as a novel approach to address left ventricular spherical remodeling in heart failure with reduced ejection fraction.
Transcatheter papillary muscle banding
open access

Original Research

Jun 17
Impact of direct left atrial pressure during TEER
Shingo Kuwata, Kentaro Hayashida, et al.

In this study, a reduction in mean left atrial pressure during mitral transcatheter edge-to-edge repair was independently associated with improved clinical outcomes in patients with degenerative mitral regurgitation, but not in those with functional mitral regurgitation.

Impact of direct left atrial pressure during TEER

new issue

Jun 15
A new issue of EuroIntervention

An ESC Clinical Consensus Statement on DAPT for secondary prevention in patients with ACS; door-to-unload time in STEMI-CS; impact of direct left atrial pressure during M-TEER; temporal trends in M-TEER for primary mitral regurgitation; transcatheter papillary muscle banding; and more

A new issue of EuroIntervention

Original Research

Jun 10
Early HVD after TAVI
Antonin Trimaille, Josep Rodés-Cabau, et al.

This large-scale, international study found that early haemodynamic valve deterioration occurred in 3.1% of TAVI patients and was independently associated with adverse clinical and haemodynamic outcomes during long-term follow-up.

Early HVD after TAVI

Editorial

Jun 11
Determinants of post-TAVI prognosis
Ron Waksman, Asa Phichaphop

The article explores the factors that influence long-term outcomes after TAVI, emphasizing the need for more research to optimize valve performance and understand the clinical significance of early post-procedure valve changes.

free

Research Correspondence

Jun 9
Unica for tricuspid regurgitation
Rodrigo Estévez-Loureiro, Neil Fam, et al.
This study reports on the compassionate use of the Unica cross-caval valve implantation device, which achieved high procedural success and significant hemodynamic improvement in patients with severe tricuspid regurgitation.
Unica for tricuspid regurgitation
Editor's Choice Podcast Listen now


UNICORN technique in native valves

Flashlight

Jun 3
UNICORN technique in native valves
Jean-Benoît Veillette, Jean-Michel Paradis, et al.
This case report describes the use of the UNICORN technique to prevent left coronary obstruction during TAVI in an 84-year-old female with severe native aortic stenosis.

Receive our newsletter
Subscribe banner

State-of-the-Art

Jun 4
TAVI and coronary interventions
Heberto Aquino Bruno, Giuseppe Tarantini, et al.
This review provides a comprehensive overview of coronary interventions related to transcatheter aortic valve implantation (TAVI), covering coronary evaluation, indications and timing of percutaneous coronary intervention, and strategies for managing coronary obstruction.
TAVI and coronary interventions
free

new issue

Jun 1
A new issue of EuroIntervention

A State-of-the-Art on TAVI and coronary interventions; early haemodynamic valve deterioration after TAVI; 30-day outcomes of redo-TAVI with SAPIEN 3; Unica device for tricuspid regurgitation; the UNICORN technique in native valves; and more

A new issue of EuroIntervention

Debate

Jun 1
Prasugrel vs ticagrelor in ACS
Dominick J. Angiolillo, Marco Valgimigli, et al.

There is an ongoing debate over whether prasugrel or ticagrelor should be the preferred P2Y12 inhibitor for patients with acute coronary syndromes, as the available evidence comparing the two remains inconclusive.

Prasugrel vs ticagrelor in ACS
free

Viewpoint

Jun 1
Full-on commitment to interventional cardiology
Bernard Prendergast et al.
The content describes the rapid evolution of interventional cardiology and the growth of the PCR organization as a global platform for education, scientific exchange, and innovation in the field.
free

Original Research

May 29
Clinical benefit of RDN through 3 years
David E. Kandzari, Felix Mahfoud, et al.
This study found significant blood pressure reductions through 36 months and that nearly 9 out of 10 patients experienced a clinical benefit after radiofrequency renal denervation using the Symplicity Spyral device.
Clinical benefit of RDN through 3 years
open access

Original Research

May 29
Ticagrelor versus clopidogrel in ACS with DOAC
Oskar Love Emilsson, Sasha Koul et al.
In ACS patients on DOACs undergoing PCI, ticagrelor was associated with a higher bleeding risk compared to clopidogrel, with no differences in ischemic outcomes.
Ticagrelor versus clopidogrel in ACS with DOAC
open access

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved